public_health

Athens – October 27, 2026 -- Month 6 interim data comparing single-dose Cecolin 9 with Gardasil 9 were presented at the 38th Annual Conference of the International Papillomavirus Society (IPVS 2026), while final results from the Phase III SHINE I study are not expected until 2028.

Navrongo researcher presents Month 6 analysis of PATH's SHINE I study

Dr. Nana A. Ansah of Ghana's Navrongo Health Research Centre presented the interim analysis of PATH's Single-dose HPV Immunobridging Study with New Vaccines (SHINE I; CVIA 104). The Phase III, double-blind, randomized, multinational study runs in Ghana and the Philippines. It compares the immunogenicity and safety of single-dose Cecolin 9, developed by Xiamen Innovax Biotech Co., Ltd. (IX), with Gardasil 9.

Participants include girls aged 9–14 and young women aged 15–20.

Fairfax – – October 19, 2026 -- Allergy & Asthma Network will hold the 12th annual USAsthma Summit on Nov. 13, 2026, in Phoenix, Arizona, with free registration for both in-person and livestream attendees.

The one-day event targets public health professionals, clinicians, asthma educators, respiratory therapists, patients, caregivers, advocates and community partners. The organizer says policymakers are considering changes that could affect access to asthma care, and the Summit is meant to address those challenges.

Summit runs alongside the ACAAI Annual Scientific Meeting in Phoenix

The event coincides with the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in the same city. That timing creates additional engagement opportunities for attendees, speakers and leaders in allergy, asthma and immunology.

Irvine, Calif. – October 07, 2026 -- MAXAIR Systems will supply a substantial quantity of its CAPR® helmet systems and related disposable equipment to World Vision for Ebola response efforts in the Democratic Republic of the Congo.

MAXAIR deepens 25-year partnership with World Vision on frontline protective gear

The Irvine, Calif.-based respiratory protection manufacturer confirmed the contribution is intended for healthcare professionals, humanitarian workers and other frontline teams operating in communities affected by the outbreak in the Democratic Republic of the Congo.

Los Angeles – – October 06, 2026 -- Vision To Learn has provided 300,000 children in California with free glasses, a milestone marked today at 24th Street Elementary School alongside the launch of a new initiative to outfit every child in Los Angeles Unified's Community Schools.

Nonprofit marks 300,000-glasses milestone with LA Unified officials

Founder Austin Beutner, California Teachers Association President David Goldberg, and LA Unified Superintendent Andrés E. Chait joined the event. Vision To Learn operates mobile vision clinics staffed by licensed eye care professionals, delivering screenings, exams and glasses directly at schools in low-income communities at no cost to families.

New York – October 05, 2026 -- A new multisector coalition launched the 30x30x50 Brain Challenge, pledging to cut stroke incidence by 30 percent and increase primary-care cognitive screening by 50 percent across 30 global cities by 2031.

Atria-coordinated coalition unites pharma, tech and the UN behind brain health delivery

The International Brain Health Coalition (IBC), coordinated by the Atria Research and Global Health Institute (ARGHI), brings together patients, multilateral institutions including the United Nations, and organizations spanning medicine, technology, and finance. Collaborators include Eli Lilly and Company, Bristol Myers Squibb, Microsoft, the Royal Bank of Canada, the American Heart Association, UN Women, Western University, and the AI-Mind Institute in Norway.

Boston – October 01, 2026 -- Blue Cross Blue Shield of Massachusetts has rolled out 100 pink-wrapped Bluebikes across its Greater Boston bike-share network, pledging $1 per ride up to $10,000 for Breast Cancer Awareness Month, with Lyft matching an additional $10,000 once that threshold is hit.

Blue Cross caps donation at $10,000, triggering a matching Lyft commitment

The fleet, split evenly between 50 classic bikes and 50 ebikes, will circulate through the Bluebikes system from October 1 to October 31. Riders need no code or sign-up; any ride on the limited-edition bikes counts toward the donation pool benefiting Ellie Fund, a Needham, Massachusetts-based nonprofit serving breast cancer patients statewide.

Washington – September 29, 2026 -- The U.S. Food and Drug Administration announced plans to evaluate changes to its application framework for new tobacco products, including e-cigarettes and nicotine pouches, aiming to simplify the pathway for these products to reach the market.

Truth Initiative warns weakened review could undermine public health protections

Kathy Crosby, CEO and President of Truth Initiative, said any changes that reduce the scientific evidence required or diminish the review process would compromise the FDA's regulatory role. The law currently requires the agency to assess a product's components, ingredients, toxicological profile and health impact, alongside risks and benefits to the broader population, including youth and non-users.

Washington – September 25, 2026 -- More than half of US adults did not attempt to get a flu, COVID-19, RSV, or pneumococcal vaccine in the past year, even though 77% agree vaccines are among the best proven tools against serious infectious disease, according to a new national survey released by the National Foundation for Infectious Diseases (NFID).

Survey finds 48% of adults tried to get at least one of four respiratory vaccines in the past year

The survey, conducted by NORC at the University of Chicago among 1,206 US adults age 18 and older between August 13-17, 2026, has a margin of sampling error of ±3.6 percentage points. Just 44% tried to get a flu vaccine and only 23% attempted a COVID-19 vaccine, despite 89% of respondents agreeing that anyone who wants vaccine access should have it and 71% saying benefits strongly outweigh risks.

Atlanta – September 19, 2026 -- E-cigarette directory laws in Alabama, Oklahoma and Louisiana produced no sustained reduction in flavored e-cigarette sales, according to a study published in JAMA Network Open by researchers from the CDC Foundation. The research, using retail scanner data from January 2021 through April 2025, marks the first rigorous evaluation of how these state registries affect nicotine sales and product availability.

Alabama and Oklahoma directories showed no measurable effect on sales

Researchers found no significant change in per-capita nicotine sales or product availability in Alabama or Oklahoma after directory implementation, using comparison states without such laws as controls.

Goleta, Calif. – September 19, 2026 -- Vitamin Angels has launched a five-year strategy targeting 477 million at-risk women and children across 57 countries by 2030, projecting it will save 360,000 children's lives and protect 10 million women and children from malnutrition.

Vitamin Angels sets numeric targets tied to global malnutrition data

The nonprofit estimates its new initiative, Vitamin Angels 2030: Science. Systems. Scale., will reduce infectious disease risk for 300,000 children ages 0-5, alongside the malnutrition protection and lives-saved figures. The launch responds to 2024 data showing 150.2 million children under five affected by stunting and 42.8 million by wasting, plus 2023 figures indicating nearly one in three women ages 15-49 experienced anemia.